Welcome : Guest

Carbylan Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Carbylan Therapeutics, Inc., which is principally involved in Clinical-Stage Specialty Pharmaceuticals Business. Illustrated with 4 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63957
Price: $200
Company Type: Public
Pages: 6
Date: November 2016
Market Data Tables: 4

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Anti-Osteoarthritis......3
Table 1: Anti-Osteoarthritis Market in Korea (2015-2020) in KRW Million......3
Diabetic Macular Edema (DME)......4
Table 2: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......4
Table 3: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......5
Anti-Osteoarthritis Medicine......6
Table 4: Market Shares of Leading Anti-Osteoarthritis Medicine Manufacturers in Korea (2015) - Percentage Breakdown by Value for Humedix Co., Ltd., and Others......6